# An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

> **NCT02555709** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vitae Pharmaceuticals Inc., an Allergan affiliate** · enrollment: 74 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** VTP-43742
- **DRUG:** Placebo 1
- **DRUG:** Placebo 2

## Key facts

- **NCT ID:** NCT02555709
- **Lead sponsor:** Vitae Pharmaceuticals Inc., an Allergan affiliate
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555709, "An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02555709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*